Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hyacyn Active (also known as Hyacyn Active Purifying Mist) is a topical skincare product developed by Hydrinity Accelerated Skin Science. Its primary active component is hypochlorous acid (HOCl) at a concentration of 0.012%. HOCl is a potent antimicrobial and anti-inflammatory agent naturally produced by human neutrophils to combat pathogens and modulate the immune response. The product is formulated as a microbiome-friendly mist designed to balance skin pH, promote wound healing, and alleviate symptoms of inflammatory skin conditions such as acne, eczema, psoriasis, and rosacea. It utilizes a proprietary delivery system with 14-nanometer particles to enhance skin penetration and is packaged in an airless, triple-walled container to ensure the stability of the HOCl for up to 24 months. Clinical data suggests that when used in conjunction with hyaluronic acid serums, it can also significantly reduce the appearance of wrinkles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hyacyn Active.